These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7720392)

  • 1. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.
    Kern TS; Engerman RL
    Curr Eye Res; 1994 Dec; 13(12):863-7. PubMed ID: 7720392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactose-induced retinal microangiopathy in rats.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia.
    Kern TS; Engerman RL
    Arch Ophthalmol; 1996 Mar; 114(3):306-10. PubMed ID: 8600891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
    Kowluru RA; Tang J; Kern TS
    Diabetes; 2001 Aug; 50(8):1938-42. PubMed ID: 11473058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A; Frank RN; Zhang NL; Samadani E
    Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Akagi Y; Neuenschwander H; Greentree W; Lackner P; Blessing K; Wyman M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1916-21. PubMed ID: 12036999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model.
    Glover JP; Jacot JL; Basso MD; Hohman TC; Robison WG
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN; Amin R; Kennedy A; Hohman TC
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.
    Robison WG; Kador PF; Kinoshita JH
    Science; 1983 Sep; 221(4616):1177-9. PubMed ID: 6612330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats.
    Roy S; Sato T; Paryani G; Kao R
    Diabetes; 2003 May; 52(5):1229-34. PubMed ID: 12716757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabeteslike proliferative retinal changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Wyman M; Ferris F
    Arch Ophthalmol; 1995 Mar; 113(3):352-4. PubMed ID: 7887849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia.
    Engerman RL; Kern TS
    Arch Ophthalmol; 1995 Mar; 113(3):355-8. PubMed ID: 7887850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model of diabetic retinopathy.
    Kern TS; Engerman RL
    Arch Ophthalmol; 1996 Aug; 114(8):986-90. PubMed ID: 8694735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia as a cause of diabetic retinopathy.
    Engerman RL; Kern TS
    Metabolism; 1986 Apr; 35(4 Suppl 1):20-3. PubMed ID: 3083205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A morphological study of the retinal vessels in experimental diabetic rats].
    Wang M; Wang YH
    Zhonghua Yan Ke Za Zhi; 1989 Jan; 25(1):31-4. PubMed ID: 2503338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus.
    Hainsworth DP; Katz ML; Sanders DA; Sanders DN; Wright EJ; Sturek M
    Comp Med; 2002 Dec; 52(6):523-9. PubMed ID: 12540165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509.
    Robinson WG; Laver NM; Jacot JL; Glover JP; Basso MD; Blouin P; Hohman TC
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1149-56. PubMed ID: 8631629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG; Laver NM; Jacot JL; Glover JP
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.